Stay updated on Rucaparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Rucaparib in Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page version has been updated from v3.5.3 to v3.5.4, indicating a routine patch or upgrade behind the scenes. This update does not change the study details or displayed information.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s revision/version identifier was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change in the underlying study information.SummaryDifference0.0%

- Check30 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check59 days agoChange DetectedNaples, Italy, 80131 was added to the locations and Napoli, Italy, 80131 was removed. The page revision tag was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check73 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check95 days agoChange DetectedFallopian tube cancer was added to the Conditions. A new Genetic and Rare Diseases Information Center resource was added under Resources, and the page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Rucaparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib in Ovarian Cancer Clinical Trial page.